← Eichor
Condition: Dtc Differentiated Thyroid Cancer Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Dtc Differentiated Thyroid Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · 33 location(s) · University College, London · NCT05604963Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Phase 2 · 5 location(s) · Children's Hospital of Philadelphia · NCT05783323Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Phase N/A · 9 location(s) · Children's Hospital of Philadelphia · NCT05024929XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Phase 2 · 2 location(s) · Jochen Lorch · NCT06959641Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT03099356Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Phase 2 · 5 location(s) · Children's Hospital of Philadelphia · NCT06458036A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer
Phase 1 · 1 location(s) · Alpha Fusion Inc. · NCT07287748Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differenti
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT07092514Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
Phase 2 · 1 location(s) · Beijing Scitech-Mq Pharmaceuticals Limited · NCT06359847Sacituzumab Tirumotecan Combined With Immunotherapy in Advanced Thyroid Cancer
NA · 1 location(s) · Zhejiang Provincial People's Hospital · NCT07068542Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyr
NA · 1 location(s) · Mayo Clinic · NCT07545837Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Amo
NA · 1 location(s) · Georgetown University · NCT06853925Iodine Uptake After a Low Iodine Diet
NA · 1 location(s) · University Medical Center Groningen · NCT05599139Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
NA · 1 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT06405217F-18 Tetrafluoroborate PET/CT in Differentiated Thyroid Cancer
NA · 2 location(s) · Ankara University · NCT07436455Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer
Phase 2 · 1 location(s) · Fudan University · NCT05989425The EMIRATES Study
Phase N/A · 1 location(s) · Royal Marsden NHS Foundation Trust · NCT06855680Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Phase 3 · 301 location(s) · ECOG-ACRIN Cancer Research Group · NCT06475989Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT05789667Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
Phase N/A · 1 location(s) · Shanghai 6th People's Hospital · NCT06671184Sacituzumab govitEcan in THYroid Cancers
Phase 2 · 11 location(s) · Grupo Espanol de Tumores Neuroendocrinos · NCT06235216Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer
Phase N/A · 1 location(s) · Mayo Clinic · NCT05575440Lateral Cervical Node Dissection in Differentiated Thyroid Cancer.
NA · 1 location(s) · Centro de Excelencia en Enfermedades de Cabeza y Cuello · NCT06149637Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Adv
NA · 1 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT06431620Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer
EARLY_Phase 1 · 1 location(s) · Peking Union Medical College Hospital · NCT06898437A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced So
Phase 1 · 83 location(s) · Pfizer · NCT05538130Pembrolizumab in High-risk Thyroid Cancer
Phase 2 · 1 location(s) · Istituti Clinici Scientifici Maugeri SpA · NCT05852223Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
Phase 3 · 29 location(s) · Centre Francois Baclesse · NCT04290663Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer
Phase 2 · 1 location(s) · Fudan University · NCT06970353The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT03841617
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.